These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 20128953)
1. Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis. Tamayo JM; Zarate CA; Vieta E; Vázquez G; Tohen M Int J Neuropsychopharmacol; 2010 Jul; 13(6):813-32. PubMed ID: 20128953 [TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome L; Ketter TA; Cucchiaro J; Loebel A J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials. Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727 [TBL] [Abstract][Full Text] [Related]
5. Balancing benefits and harms of treatments for acute bipolar depression. Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911 [TBL] [Abstract][Full Text] [Related]
6. Lithium for acute mania. McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444 [TBL] [Abstract][Full Text] [Related]
7. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. Sidor MM; Macqueen GM J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686 [TBL] [Abstract][Full Text] [Related]
8. Treatment of bipolar depression: making sensible decisions. Citrome L CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of treatments for bipolar depression. Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634 [TBL] [Abstract][Full Text] [Related]
10. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis. Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254 [TBL] [Abstract][Full Text] [Related]
13. Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic. Citrome L Int J Clin Pract; 2009 Dec; 63(12):1762-84. PubMed ID: 19840150 [TBL] [Abstract][Full Text] [Related]
14. Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis. Bond DJ; Lam RW; Yatham LN J Affect Disord; 2010 Aug; 124(3):228-34. PubMed ID: 20044142 [TBL] [Abstract][Full Text] [Related]
16. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797 [TBL] [Abstract][Full Text] [Related]
17. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862 [TBL] [Abstract][Full Text] [Related]
18. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence]. Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089 [TBL] [Abstract][Full Text] [Related]
19. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]